Annual CFF
Summary
- Current Value
- As of today, AGL annual cash from financing is -$2.58M, up +98.66% on
- Historical Performance
- AGL annual cash from financing is down -100.22% over the past 3 years, and down -101.47% over the past 5 years
- All-Time High Comparison
- AGL annual cash from financing is currently -100.22% below its historical high of $1.15B set on
- 3-Year Low Comparison
- AGL annual cash from financing is +98.66% above its 3-year low of -$193.13M reached on
- Sector Comparison
- AGL annual cash from financing is higher than 19.81% of companies in Healthcare sector
Cash From Financing Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | -$2.58M | +98.7% | -100.2% | -101.5% | -101.5% | |
| Quarterly Cash From Financing | -$236.00K | +83.2% | -102.6% | +96.2% | -100.9% | |
| TTM Cash From Financing | -$3.00M | +11.9% | -108.0% | -111.8% | -111.0% | |
| Price | $0.98 | -72.3% | -95.2% | – | – | |
| Annual Cash From Operations | -$57.78M | +63.0% | +61.0% | +44.4% | +44.4% | |
| Annual Cash From Investing | $139.89M | +417.8% | +254.6% | +2864.6% | +2864.6% | |
| $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | ||
| Annual Total Debt | $43.96M | -16.0% | -26.3% | -45.9% | -45.9% | |
| Shares Outstanding | 414.58M | +0.6% | +0.5% | +7.7% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $28.06M | N/A | -109.2% |
| 5Y | $1.15B | -100.2% | |
| All | $1.15B | -100.2% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$193.13M | +98.7% | |
| 5Y | -$193.13M | +98.7% | |
| All | -$193.13M | +98.7% |
Cash From Financing History
| Year | Value | Change |
|---|---|---|
| -$2.58M | +98.7% | |
| -$193.13M | -788.4% | |
| $28.06M | -97.6% |
| Year | Value | Change |
|---|---|---|
| $1.15B | +4,588.6% | |
| $24.62M | -86.0% | |
| $176.30M | - |
FAQ
What is the current annual cash from financing of AGL?
As of today, AGL annual cash from financing is -$2.58M
What is 1-year change in AGL annual cash from financing?
AGL annual cash from financing is up +98.66% year-over-year
What is 3-year change in AGL annual cash from financing?
AGL annual cash from financing is down -100.22% over the past 3 years
How far is AGL annual cash from financing from its all-time high?
AGL annual cash from financing is currently -100.22% below its historical high of $1.15B set on December 31, 2021
How does AGL annual cash from financing rank versus sector peers?
AGL annual cash from financing is higher than 19.81% of companies in Healthcare sector
When is AGL next annual earnings release?
The next annual earnings release for AGL is on
Quarterly CFF
Summary
- Current Value
- As of today, AGL quarterly cash from financing is -$236.00K, up +90.85% on
- Historical Performance
- AGL quarterly cash from financing is up +83.21% year-over-year, and down -102.59% over the past 3 years
- All-Time High Comparison
- AGL quarterly cash from financing is currently -100.02% below its historical high of $1.11B set on
- 3-Year Low Comparison
- AGL quarterly cash from financing is +99.88% above its 3-year low of -$202.04M reached on
- Sector Comparison
- AGL quarterly cash from financing is higher than 27.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | -$236.00K | +90.8% | +83.2% | -102.6% | +96.2% | |
| Annual Cash From Financing | -$2.58M | – | +98.7% | -100.2% | -101.5% | |
| TTM Cash From Financing | -$3.00M | +28.1% | +11.9% | -108.0% | -111.8% | |
| Price | $0.98 | +4.4% | -72.3% | -95.2% | – | |
| Quarterly Cash From Operations | -$18.15M | +48.3% | -135.7% | -785.8% | -315.7% | |
| Quarterly Cash From Investing | $18.66M | -73.5% | -59.9% | +114.3% | +1532.4% | |
| $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | ||
| Quarterly Total Debt | $37.12M | -10.3% | -15.4% | -32.5% | +100.0% | |
| Shares Outstanding | 414.58M | – | +0.6% | +0.5% | +7.7% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$22.00K | N/A | -972.7% |
| 3Y | $8.34M | -102.8% | |
| 5Y | $1.11B | -100.0% | |
| All | $1.11B | -100.0% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$2.58M | +90.8% | |
| 3Y | -$202.04M | +99.9% | |
| 5Y | -$202.04M | +99.9% | |
| All | -$202.04M | +99.9% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of AGL?
As of today, AGL quarterly cash from financing is -$236.00K
What is AGL quarterly cash from financing most recent change?
AGL quarterly cash from financing was up +90.85% on September 30, 2025
What is 1-year change in AGL quarterly cash from financing?
AGL quarterly cash from financing is up +83.21% year-over-year
How far is AGL quarterly cash from financing from its all-time high?
AGL quarterly cash from financing is currently -100.02% below its historical high of $1.11B set on June 30, 2021
How does AGL quarterly cash from financing rank versus sector peers?
AGL quarterly cash from financing is higher than 27.27% of companies in Healthcare sector
When is AGL next earnings release?
The next earnings release for AGL is on
TTM CFF
Summary
- Current Value
- As of today, AGL TTM cash from financing is -$3.00M, up +28.06% on
- Historical Performance
- AGL TTM cash from financing is up +11.95% year-over-year, and down -108.03% over the past 3 years
- All-Time High Comparison
- AGL TTM cash from financing is currently -100.26% below its historical high of $1.15B set on
- 3-Year Low Comparison
- AGL TTM cash from financing is +98.51% above its 3-year low of -$200.91M reached on
- Sector Comparison
- AGL TTM cash from financing is higher than 22.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$3.00M | +28.1% | +11.9% | -108.0% | -111.8% | |
| Annual Cash From Financing | -$2.58M | – | +98.7% | -100.2% | -101.5% | |
| Quarterly Cash From Financing | -$236.00K | +90.8% | +83.2% | -102.6% | +96.2% | |
| Price | $0.98 | +4.4% | -72.3% | -95.2% | – | |
| TTM Cash From Operations | -$68.81M | -17.9% | +49.2% | +47.0% | -72.6% | |
| TTM Cash From Investing | $89.70M | -23.7% | -21.3% | +120.4% | +7525.5% | |
| $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | ||
| Quarterly Total Debt | $37.12M | -10.3% | -15.4% | -32.5% | +100.0% | |
| Shares Outstanding | 414.58M | – | +0.6% | +0.5% | +7.7% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$2.58M | N/A | -16.1% |
| 3Y | $28.06M | N/A | -110.7% |
| 5Y | $1.15B | -100.3% | |
| All | $1.15B | -100.3% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$4.17M | +28.1% | |
| 3Y | -$200.91M | +98.5% | |
| 5Y | -$200.91M | +98.5% | |
| All | -$200.91M | +98.5% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of AGL?
As of today, AGL TTM cash from financing is -$3.00M
What is AGL TTM cash from financing most recent change?
AGL TTM cash from financing was up +28.06% on September 30, 2025
What is 1-year change in AGL TTM cash from financing?
AGL TTM cash from financing is up +11.95% year-over-year
How far is AGL TTM cash from financing from its all-time high?
AGL TTM cash from financing is currently -100.26% below its historical high of $1.15B set on December 31, 2021
How does AGL TTM cash from financing rank versus sector peers?
AGL TTM cash from financing is higher than 22.27% of companies in Healthcare sector
When is AGL next earnings release?
The next earnings release for AGL is on
Cash From Financing Formula
Data Sources & References
- AGL Official Website www.agilonhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1831097/000162828025048839/0001628280-25-048839-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1831097/000162828025007721/0001628280-25-007721-index.htm
- AGL Profile on Yahoo Finance finance.yahoo.com/quote/AGL
- AGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/agl
